Strange trip: why Trump is backing psychedelics
Last month President Trump signed an executive order designed to fast track both research and access to psychedelic drugs as treatments for mental health illnesses. The most prominent in the order was ibogaine, a drug derived from the root bark of a West African shrub, that has shown some promise in relieving the long…
We score an episode from what we can actually measure — its reach and engagement, what listeners say about it, and what it covers. We don't have those signals for this one yet, so it doesn't get a number.
Buzzmeter says it's buzzing across platforms — the Hive Vote says whether the people who actually listened liked it.
Rate this episode
Add your vote to the Hive — listeners rate every episode after they finish.
- No reviews yet — be the first.
Similar episodes from other shows
More like Science Weekly →
What is ibogaine, and why is it in the news?
How science is taking tripping mainstream
The future of psychedelic-assisted psychotherapy | Rick Doblin
Ibogaine: A Miracle Psychedelic?
One great episode in your inbox, daily — free.
One email a day, unsubscribe anytime. No spam, ever.